Bionime Corporation (TPE:4737)
Taiwan · Delayed Price · Currency is TWD 65.10
+0.20 (0.31%)
At close: Mar 27, 2026
Bionime Revenue
In the year 2025, Bionime had annual revenue of 1.84B TWD, down -4.92%. Bionime had revenue of 426.96M in the quarter ending December 31, 2025, a decrease of -14.98%.
Revenue
1.84B
Revenue Growth
-4.92%
P/S Ratio
2.38
Revenue / Employee
3.68M
Employees
500
Market Cap
4.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.84B | -95.16M | -4.92% |
| Dec 31, 2024 | 1.93B | 178.18M | 10.15% |
| Dec 31, 2023 | 1.76B | -455.02M | -20.58% |
| Dec 31, 2022 | 2.21B | 360.67M | 19.50% |
| Dec 31, 2021 | 1.85B | 181.34M | 10.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Formosa Optical Technology | 4.13B |
| St.Shine Optical | 4.12B |
| Pacific Hospital Supply | 2.41B |
| Nang Kuang Pharmaceutical | 2.16B |
| Bioteque | 2.14B |
| Chi Sheng Pharma & Biotech | 1.38B |
| ICARES Medicus | 1.13B |
| Crystalvue Medical | 949.05M |